Doering, J., Hecker, M., Villeneuve, D. L., & Zhang, X. (2019). Adverse Outcome Pathway on aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2. OECD Publishing.
Chicago Style (17th ed.) CitationDoering, Jon, Markus Hecker, Daniel L. Villeneuve, and Xiaowei Zhang. Adverse Outcome Pathway on Aryl Hydrocarbon Receptor Activation Leading to Early Life Stage Mortality, via Increased COX-2. Paris: OECD Publishing, 2019.
MLA (9th ed.) CitationDoering, Jon, et al. Adverse Outcome Pathway on Aryl Hydrocarbon Receptor Activation Leading to Early Life Stage Mortality, via Increased COX-2. OECD Publishing, 2019.
Warning: These citations may not always be 100% accurate.